Skip to main content
. 2018 Feb 3;2(2):299–309. doi: 10.1002/rth2.12079

Table 3.

Hazard ratios of recurrent VTE by risk factors

Risk factor Hazard ratioa 95% CI Hazard ratioa 95% CI
Unadjusted Adjusted
Provoking risk factors (mutually exclusive groups)
 Provoked by surgeryc 1.0 1.0
 Non‐surgical transient risk factorc 1.8 0.7, 4.8 1.6 0.5, 5.5
 Unprovoked VTEc 3.1 1.3, 7.4 4.6 1.7, 11.9
 Active cancerc N/A N/A
Other risk factors
 Male sex 2.0 1.2, 3.3 2.8 1.5, 5.1
 Pregnancy 1.1 0.2, 8.1 1.9 0.2, 15.1
 Contraceptive use at the time of thrombosis 0.1 0.0, 0.9 0.1 0.0, 0.9
 Traveling 1.8 0.9, 3.8 1.5 0.6, 3.8
 Immobilization 0.4 0.1, 1.6 0.2 0.0, 1.5
 Inflammation 1.9 1.1, 3.4 1.8 0.9, 3.4
 Previous VTE 0.7 0.3, 1.3 0.8 0.3, 1.8
 Cardiovascular disease 1.3 0.7, 2.2 1.1 0.6, 2.2
 Heart failure 1.0 0.1, 7.4 2.0 0.3, 15.2
 Known thrombophilia 0.4 0.1, 2.7 0.6 0.1, 4.8
 Varicose veins 0.8 0.3, 2.6 1.0 0.3, 3.4
 Smoking 0.8 0.4, 1.5 0.7 0.4, 1.5
 Family history 0.8 0.5, 1.5 0.9 0.5, 1.7
Risk factors not assessed at baseline
 Residual thrombosisd 1.0 0.6, 1.7 1.1 0.6, 2.0
 Elevated Villalta scoree , f 1.6 0.9, 3.0 1.6 0.8, 3.5
 Elevated D‐dimerb, g 2.5 1.5, 4.3 3.3 1.8, 6.1
 High factor VIIIb, g 2.3 1.3, 4.2 2.2 1.2, 4.0
 Elevated CRPb, g 1.8 1.0, 3.2 1.5 0.8, 2.7
a

Cox proportional hazards model.

b

Adjusted by anticoagulation (time‐varying co‐variable), age, surgery, pregnancy, contraceptive use at the time of thrombosis, travel, inflammation, sex, previous VTE, D‐dimer, and Factor VIII levels.

c

Groups are mutually exclusive, reference is provoked by surgery.

d

Assessed one week before intended cessation of anticoagulation treatment.

e

Assessed at six months.

f

≥5 points.

g

Assessed one month after stop anticoagulation treatment.